Our findings on the proteolytic processing of ephrin-B provide information about adverse side effects of γ-secretase inhibitors for the treatment of Alzheimer disease, as well as a novel direction for understanding the molecular mechanism of Eph-ephrin-B signaling. This evidence concerns the gene EPHA1 and Alzheimer disease.